Literature DB >> 6999021

Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system.

P C de Girolami, L A Maher, M T Booth, D M St George.   

Abstract

A total of 509 clinical isolates of Enterobacteriaceae were tested for susceptibility to cefamandole by Autobac 1 and Bauer-Kirby disk diffusion methods, using commercially available 30-micrograms cefamandole disks. Minimal inhibitory concentrations were determined for all organisms showing major or very major discrepancies. Overall agreement between Autobac 1 and disk diffusion was 89.8%, with 5.1% major or very major and 5.1% minor discrepancies. When considering only the genera for which 20 or more isolates were tested, overall agreement was 90.8%. Discrepancies for Escherichia coli showed a trend toward resistance by Autobac 1, with minimal inhibitory concentrations generally in agreement with disk diffusion results. No trends were detected for other genera. The rate of agreement was lower for Enterobacter species (75.4%), but minimal inhibitory concentrations, determined for all discrepancies in this genus, agreed with Autobafc 1 as often a with disk diffusion results.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6999021      PMCID: PMC273633          DOI: 10.1128/jcm.12.4.546-549.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Laboratory evaluation of a rapid, automatic susceptibility testing system: report of a collaborative study.

Authors:  C Thornsberry; T L Gavan; J C Sherris; A Balows; J M Matsen; L D Sabath; F Schoenknecht; L D Thrupp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

2.  Cefuroxime, an in vitro Comparison with Six Other Cephalosporins.

Authors:  A L Barry; C Thornsberry; R N Jones; P C Fuchs; T L Gavan; E H Gerlach
Journal:  Proc R Soc Med       Date:  1977

3.  Pharmacological studies with cefamandole in human volunteers.

Authors:  B R Meyers; B Ribner; S Yancovitz; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

4.  Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance.

Authors:  C M Findell; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

5.  Simplified storage and retrieval of stock cultures.

Authors:  J G Ngel; L J Kunz
Journal:  Appl Microbiol       Date:  1972-04

6.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

7.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

8.  In vitro evaluation of cefoxitin and cefamandole.

Authors:  H G Adams; G A Stilwell; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

9.  In vitro studies of cefamandole.

Authors:  G P Bodey; S Weaver
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

10.  In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.

Authors:  A L Barry; F D Schoenknect; S Shadomy; J C Sherris; C Thornsberry; J A Washington; R B Kammer
Journal:  Am J Clin Pathol       Date:  1979-11       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.